https://doi.org/10.1186/s12967-023-04060-3
Y
Yan Lin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
184
Citations
7
h-index
6
i10-index
Yan Lin is an academic researcher from China Pharmaceutical University. The author has contributed to research in topics: Chinese history and philosophy & Cancer Immunotherapy and Biomarkers & Microfinance and Financial Inclusion. The author has an h-index of 7, co-authored 45 publications.
ORCID: 0000-0001-8184-6275Papers by this author
worksTumor cell density dependent IL-8 secretion induces the fluctuation of tregs/CD8 + T cells infiltration in hepatocellular carcinoma: one prompt for the existence of density checkpoint
2023 · Journal of Translational Medicine · 13 citations
Dihydrotanshinone I Attenuates Diet‐Induced Nonalcoholic Fatty Liver Disease via Up‐Regulation of <scp>IRG1</scp>
2025 · Phytotherapy Research · 4 citations
https://doi.org/10.1002/ptr.8443
PROM2 exacerbates CCl4-Induced liver fibrosis via NLRP3 inflammasome activation and hepatocyte pyroptosis
2025 · Cellular and Molecular Life Sciences · 1 citations
https://doi.org/10.1007/s00018-025-05920-5
A prospective single arm cohort study: An analysis of the effectiveness of surgical treatment of locally advanced breast cancer
2024 · Heliyon · 0 citations
https://doi.org/10.1016/j.heliyon.2024.e36279
A Novel Prognostic Model to Predict 1-Year Post-Transplant Mortality for Acute-on-Chronic Hepatitis B Liver Failure: A Nationwide, Multicenter, Cohort Study
2025 · American Journal of Transplantation · 0 citations
https://doi.org/10.1016/j.ajt.2025.07.1104
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat